Crossmark

Mechanistic Approach for Protective Effect of ARA290, a Specific Ligand for the Erythropoietin/CD131 Heteroreceptor, against Cisplatin-Induced Nephrotoxicity, the Involvement of Apoptosis and Inflammation Pathways

Crossref DOI link: https://doi.org/10.1007/s10753-022-01737-7

Published Online: 2022-09-10

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ghassemi-Barghi, Nasrin

Ehsanfar, Zeynab

Mohammadrezakhani, Omid

Ashari, Sorour

Ghiabi, Shamim

Bayrami, Zahra
License Information

Text and Data Mining valid from 2022-09-10

Version of Record valid from 2022-09-10
More Information

Article History

Received: 9 July 2022

Revised: 8 August 2022

Accepted: 30 August 2022

First Online: 10 September 2022

DECLARATIONS

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below